Gabapentinoid Use Continues to Climb
Gabapentin still commonly prescribed off-label for chronic pain
Stay updated with breaking news from Donovan Maust. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Gabapentin still commonly prescribed off-label for chronic pain
Patients who discontinued long-term benzodiazepines had a higher risk of death
A research team led by UMich received funding for the next five years expected to amount to $81 million to improve dementia care.
Watching a loved one suffer the slow decline of dementia is hard enough. But trying to find care for them that's high-quality, safe, available and affordable is nearly as difficult, as millions of American families have found out the hard way in recent years.
Despite the warnings against long-term use, many of us are reliant on medication with serious risks of side effects